nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—HRH1—Dimenhydrinate—atopic dermatitis	0.109	0.152	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0629	0.0883	CbGbCtD
Iloperidone—CYP3A7—Tacrolimus—atopic dermatitis	0.0629	0.0883	CbGbCtD
Iloperidone—HRH1—Loratadine—atopic dermatitis	0.053	0.0744	CbGbCtD
Iloperidone—HRH1—Diphenhydramine—atopic dermatitis	0.053	0.0744	CbGbCtD
Iloperidone—CYP3A5—Tacrolimus—atopic dermatitis	0.0472	0.0662	CbGbCtD
Iloperidone—CYP3A4—Pimecrolimus—atopic dermatitis	0.0309	0.0434	CbGbCtD
Iloperidone—CYP1A2—Diphenhydramine—atopic dermatitis	0.0257	0.0361	CbGbCtD
Iloperidone—CYP3A7—Hydrocortisone—atopic dermatitis	0.0256	0.0359	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0256	0.0359	CbGbCtD
Iloperidone—CYP2D6—Diphenhydramine—atopic dermatitis	0.0212	0.0297	CbGbCtD
Iloperidone—CYP2D6—Loratadine—atopic dermatitis	0.0212	0.0297	CbGbCtD
Iloperidone—CYP3A5—Hydrocortisone—atopic dermatitis	0.0192	0.027	CbGbCtD
Iloperidone—CYP3A4—Tacrolimus—atopic dermatitis	0.0184	0.0258	CbGbCtD
Iloperidone—CYP3A7—Dexamethasone—atopic dermatitis	0.0159	0.0223	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.0159	0.0223	CbGbCtD
Iloperidone—CYP2E1—Dexamethasone—atopic dermatitis	0.0154	0.0216	CbGbCtD
Iloperidone—CYP3A4—Loratadine—atopic dermatitis	0.0135	0.0189	CbGbCtD
Iloperidone—CYP3A4—Methylprednisolone—atopic dermatitis	0.0123	0.0173	CbGbCtD
Iloperidone—CYP3A5—Dexamethasone—atopic dermatitis	0.0119	0.0168	CbGbCtD
Iloperidone—CYP3A4—Triamcinolone—atopic dermatitis	0.00933	0.0131	CbGbCtD
Iloperidone—CYP3A4—Betamethasone—atopic dermatitis	0.008	0.0112	CbGbCtD
Iloperidone—CYP3A4—Prednisolone—atopic dermatitis	0.0079	0.0111	CbGbCtD
Iloperidone—CYP3A4—Hydrocortisone—atopic dermatitis	0.00749	0.0105	CbGbCtD
Iloperidone—CYP3A4—Prednisone—atopic dermatitis	0.00746	0.0105	CbGbCtD
Iloperidone—CYP2D6—Dexamethasone—atopic dermatitis	0.00732	0.0103	CbGbCtD
Iloperidone—CYP3A4—Dexamethasone—atopic dermatitis	0.00466	0.00654	CbGbCtD
Iloperidone—SIGMAR1—Levonorgestrel—Hydrocortisone—atopic dermatitis	0.000947	1	CbGdCrCtD
Iloperidone—Increased appetite—Dexamethasone—atopic dermatitis	0.000326	0.00152	CcSEcCtD
Iloperidone—Increased appetite—Betamethasone—atopic dermatitis	0.000326	0.00152	CcSEcCtD
Iloperidone—Tremor—Tacrolimus—atopic dermatitis	0.000324	0.00151	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.000323	0.00151	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000321	0.0015	CcSEcCtD
Iloperidone—Anaemia—Tacrolimus—atopic dermatitis	0.00032	0.00149	CcSEcCtD
Iloperidone—Mood swings—Triamcinolone—atopic dermatitis	0.00032	0.00149	CcSEcCtD
Iloperidone—Mood swings—Methylprednisolone—atopic dermatitis	0.000319	0.00149	CcSEcCtD
Iloperidone—Nausea—Dimenhydrinate—atopic dermatitis	0.000319	0.00149	CcSEcCtD
Iloperidone—Nausea—Diphenhydramine—atopic dermatitis	0.000319	0.00149	CcSEcCtD
Iloperidone—Paraesthesia—Mometasone—atopic dermatitis	0.000319	0.00149	CcSEcCtD
Iloperidone—Agitation—Tacrolimus—atopic dermatitis	0.000318	0.00149	CcSEcCtD
Iloperidone—Dyspnoea—Mometasone—atopic dermatitis	0.000317	0.00148	CcSEcCtD
Iloperidone—Cardiac failure—Dexamethasone—atopic dermatitis	0.000314	0.00147	CcSEcCtD
Iloperidone—Cardiac failure—Betamethasone—atopic dermatitis	0.000314	0.00147	CcSEcCtD
Iloperidone—Lethargy—Dexamethasone—atopic dermatitis	0.000313	0.00146	CcSEcCtD
Iloperidone—Lethargy—Betamethasone—atopic dermatitis	0.000313	0.00146	CcSEcCtD
Iloperidone—Vertigo—Tacrolimus—atopic dermatitis	0.000311	0.00145	CcSEcCtD
Iloperidone—Leukopenia—Tacrolimus—atopic dermatitis	0.00031	0.00145	CcSEcCtD
Iloperidone—Nausea—Pimecrolimus—atopic dermatitis	0.000308	0.00144	CcSEcCtD
Iloperidone—Fatigue—Mometasone—atopic dermatitis	0.000306	0.00143	CcSEcCtD
Iloperidone—Palpitations—Tacrolimus—atopic dermatitis	0.000306	0.00143	CcSEcCtD
Iloperidone—Breast disorder—Methylprednisolone—atopic dermatitis	0.000304	0.00142	CcSEcCtD
Iloperidone—Affect lability—Dexamethasone—atopic dermatitis	0.000302	0.00141	CcSEcCtD
Iloperidone—Affect lability—Betamethasone—atopic dermatitis	0.000302	0.00141	CcSEcCtD
Iloperidone—Psychotic disorder—Betamethasone—atopic dermatitis	0.000299	0.0014	CcSEcCtD
Iloperidone—Psychotic disorder—Dexamethasone—atopic dermatitis	0.000299	0.0014	CcSEcCtD
Iloperidone—Asthenia—Loratadine—atopic dermatitis	0.000297	0.00139	CcSEcCtD
Iloperidone—Myalgia—Tacrolimus—atopic dermatitis	0.000295	0.00138	CcSEcCtD
Iloperidone—Arthralgia—Tacrolimus—atopic dermatitis	0.000295	0.00138	CcSEcCtD
Iloperidone—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000294	0.00137	CcSEcCtD
Iloperidone—Asthma—Triamcinolone—atopic dermatitis	0.000292	0.00136	CcSEcCtD
Iloperidone—Mood swings—Betamethasone—atopic dermatitis	0.00029	0.00136	CcSEcCtD
Iloperidone—Mood swings—Dexamethasone—atopic dermatitis	0.00029	0.00136	CcSEcCtD
Iloperidone—Weight increased—Prednisolone—atopic dermatitis	0.000289	0.00135	CcSEcCtD
Iloperidone—Dry mouth—Tacrolimus—atopic dermatitis	0.000288	0.00135	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000288	0.00135	CcSEcCtD
Iloperidone—Confusional state—Tacrolimus—atopic dermatitis	0.000285	0.00133	CcSEcCtD
Iloperidone—Amnesia—Prednisone—atopic dermatitis	0.000284	0.00133	CcSEcCtD
Iloperidone—Increased appetite—Prednisone—atopic dermatitis	0.000284	0.00133	CcSEcCtD
Iloperidone—Diarrhoea—Loratadine—atopic dermatitis	0.000283	0.00132	CcSEcCtD
Iloperidone—Oedema—Tacrolimus—atopic dermatitis	0.000283	0.00132	CcSEcCtD
Iloperidone—Weight increased—Hydrocortisone—atopic dermatitis	0.000282	0.00132	CcSEcCtD
Iloperidone—Infection—Tacrolimus—atopic dermatitis	0.000281	0.00131	CcSEcCtD
Iloperidone—Body temperature increased—Mometasone—atopic dermatitis	0.000281	0.00131	CcSEcCtD
Iloperidone—Weight decreased—Hydrocortisone—atopic dermatitis	0.00028	0.00131	CcSEcCtD
Iloperidone—Hypokalaemia—Betamethasone—atopic dermatitis	0.000279	0.0013	CcSEcCtD
Iloperidone—Hypokalaemia—Dexamethasone—atopic dermatitis	0.000279	0.0013	CcSEcCtD
Iloperidone—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000277	0.00129	CcSEcCtD
Iloperidone—Tachycardia—Tacrolimus—atopic dermatitis	0.000276	0.00129	CcSEcCtD
Iloperidone—Conjunctivitis—Prednisolone—atopic dermatitis	0.000275	0.00128	CcSEcCtD
Iloperidone—Dizziness—Loratadine—atopic dermatitis	0.000274	0.00128	CcSEcCtD
Iloperidone—Cardiac failure—Prednisone—atopic dermatitis	0.000273	0.00128	CcSEcCtD
Iloperidone—Lethargy—Prednisone—atopic dermatitis	0.000272	0.00127	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000271	0.00127	CcSEcCtD
Iloperidone—Weight increased—Triamcinolone—atopic dermatitis	0.000266	0.00124	CcSEcCtD
Iloperidone—Weight increased—Methylprednisolone—atopic dermatitis	0.000265	0.00124	CcSEcCtD
Iloperidone—Hypotension—Tacrolimus—atopic dermatitis	0.000264	0.00123	CcSEcCtD
Iloperidone—Affect lability—Prednisone—atopic dermatitis	0.000263	0.00123	CcSEcCtD
Iloperidone—Rash—Loratadine—atopic dermatitis	0.000261	0.00122	CcSEcCtD
Iloperidone—Psychotic disorder—Prednisone—atopic dermatitis	0.000261	0.00122	CcSEcCtD
Iloperidone—Dermatitis—Loratadine—atopic dermatitis	0.000261	0.00122	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000257	0.0012	CcSEcCtD
Iloperidone—Asthenia—Mometasone—atopic dermatitis	0.000255	0.00119	CcSEcCtD
Iloperidone—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000254	0.00119	CcSEcCtD
Iloperidone—Paraesthesia—Tacrolimus—atopic dermatitis	0.000254	0.00118	CcSEcCtD
Iloperidone—Conjunctivitis—Triamcinolone—atopic dermatitis	0.000253	0.00118	CcSEcCtD
Iloperidone—Mood swings—Prednisone—atopic dermatitis	0.000253	0.00118	CcSEcCtD
Iloperidone—Dyspnoea—Tacrolimus—atopic dermatitis	0.000252	0.00118	CcSEcCtD
Iloperidone—Somnolence—Tacrolimus—atopic dermatitis	0.000251	0.00117	CcSEcCtD
Iloperidone—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000246	0.00115	CcSEcCtD
Iloperidone—Nausea—Loratadine—atopic dermatitis	0.000246	0.00115	CcSEcCtD
Iloperidone—Epistaxis—Triamcinolone—atopic dermatitis	0.000245	0.00115	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000244	0.00114	CcSEcCtD
Iloperidone—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000244	0.00114	CcSEcCtD
Iloperidone—Fatigue—Tacrolimus—atopic dermatitis	0.000244	0.00114	CcSEcCtD
Iloperidone—Diarrhoea—Mometasone—atopic dermatitis	0.000243	0.00113	CcSEcCtD
Iloperidone—Hypokalaemia—Prednisone—atopic dermatitis	0.000243	0.00113	CcSEcCtD
Iloperidone—Weight increased—Betamethasone—atopic dermatitis	0.000241	0.00113	CcSEcCtD
Iloperidone—Weight increased—Dexamethasone—atopic dermatitis	0.000241	0.00113	CcSEcCtD
Iloperidone—Weight decreased—Dexamethasone—atopic dermatitis	0.00024	0.00112	CcSEcCtD
Iloperidone—Weight decreased—Betamethasone—atopic dermatitis	0.00024	0.00112	CcSEcCtD
Iloperidone—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000234	0.00109	CcSEcCtD
Iloperidone—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000234	0.00109	CcSEcCtD
Iloperidone—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000233	0.00109	CcSEcCtD
Iloperidone—Eye disorder—Hydrocortisone—atopic dermatitis	0.000232	0.00108	CcSEcCtD
Iloperidone—Conjunctivitis—Dexamethasone—atopic dermatitis	0.00023	0.00107	CcSEcCtD
Iloperidone—Conjunctivitis—Betamethasone—atopic dermatitis	0.00023	0.00107	CcSEcCtD
Iloperidone—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000229	0.00107	CcSEcCtD
Iloperidone—Arrhythmia—Prednisolone—atopic dermatitis	0.000227	0.00106	CcSEcCtD
Iloperidone—Rash—Mometasone—atopic dermatitis	0.000224	0.00105	CcSEcCtD
Iloperidone—Dermatitis—Mometasone—atopic dermatitis	0.000224	0.00104	CcSEcCtD
Iloperidone—Body temperature increased—Tacrolimus—atopic dermatitis	0.000223	0.00104	CcSEcCtD
Iloperidone—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000222	0.00104	CcSEcCtD
Iloperidone—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000221	0.00103	CcSEcCtD
Iloperidone—Eye disorder—Methylprednisolone—atopic dermatitis	0.000218	0.00102	CcSEcCtD
Iloperidone—Mental disorder—Hydrocortisone—atopic dermatitis	0.000217	0.00102	CcSEcCtD
Iloperidone—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000216	0.00101	CcSEcCtD
Iloperidone—Malnutrition—Hydrocortisone—atopic dermatitis	0.000216	0.00101	CcSEcCtD
Iloperidone—Erectile dysfunction—Prednisone—atopic dermatitis	0.000212	0.000992	CcSEcCtD
Iloperidone—Angiopathy—Methylprednisolone—atopic dermatitis	0.000211	0.000988	CcSEcCtD
Iloperidone—Nausea—Mometasone—atopic dermatitis	0.000211	0.000985	CcSEcCtD
Iloperidone—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.00021	0.000981	CcSEcCtD
Iloperidone—Weight increased—Prednisone—atopic dermatitis	0.00021	0.00098	CcSEcCtD
Iloperidone—Arrhythmia—Triamcinolone—atopic dermatitis	0.000209	0.000975	CcSEcCtD
Iloperidone—Weight decreased—Prednisone—atopic dermatitis	0.000209	0.000974	CcSEcCtD
Iloperidone—Vision blurred—Prednisolone—atopic dermatitis	0.000208	0.000973	CcSEcCtD
Iloperidone—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000208	0.000972	CcSEcCtD
Iloperidone—Mental disorder—Methylprednisolone—atopic dermatitis	0.000204	0.000954	CcSEcCtD
Iloperidone—Malnutrition—Methylprednisolone—atopic dermatitis	0.000203	0.000948	CcSEcCtD
Iloperidone—Asthenia—Tacrolimus—atopic dermatitis	0.000203	0.000947	CcSEcCtD
Iloperidone—Vertigo—Prednisolone—atopic dermatitis	0.000199	0.000928	CcSEcCtD
Iloperidone—Eye disorder—Dexamethasone—atopic dermatitis	0.000198	0.000925	CcSEcCtD
Iloperidone—Eye disorder—Betamethasone—atopic dermatitis	0.000198	0.000925	CcSEcCtD
Iloperidone—Vertigo—Hydrocortisone—atopic dermatitis	0.000194	0.000906	CcSEcCtD
Iloperidone—Diarrhoea—Tacrolimus—atopic dermatitis	0.000193	0.000903	CcSEcCtD
Iloperidone—Angiopathy—Betamethasone—atopic dermatitis	0.000192	0.000898	CcSEcCtD
Iloperidone—Angiopathy—Dexamethasone—atopic dermatitis	0.000192	0.000898	CcSEcCtD
Iloperidone—Arrhythmia—Betamethasone—atopic dermatitis	0.000189	0.000884	CcSEcCtD
Iloperidone—Arrhythmia—Dexamethasone—atopic dermatitis	0.000189	0.000884	CcSEcCtD
Iloperidone—Dizziness—Tacrolimus—atopic dermatitis	0.000187	0.000873	CcSEcCtD
Iloperidone—Myalgia—Hydrocortisone—atopic dermatitis	0.000184	0.000859	CcSEcCtD
Iloperidone—Vertigo—Triamcinolone—atopic dermatitis	0.000183	0.000853	CcSEcCtD
Iloperidone—Vertigo—Methylprednisolone—atopic dermatitis	0.000182	0.000851	CcSEcCtD
Iloperidone—Connective tissue disorder—Prednisone—atopic dermatitis	0.000181	0.000847	CcSEcCtD
Iloperidone—Oedema—Prednisolone—atopic dermatitis	0.00018	0.000843	CcSEcCtD
Iloperidone—Rash—Tacrolimus—atopic dermatitis	0.000178	0.000832	CcSEcCtD
Iloperidone—Dermatitis—Tacrolimus—atopic dermatitis	0.000178	0.000831	CcSEcCtD
Iloperidone—Oedema—Hydrocortisone—atopic dermatitis	0.000176	0.000823	CcSEcCtD
Iloperidone—Tachycardia—Prednisolone—atopic dermatitis	0.000176	0.000823	CcSEcCtD
Iloperidone—Infection—Hydrocortisone—atopic dermatitis	0.000175	0.000818	CcSEcCtD
Iloperidone—Myalgia—Triamcinolone—atopic dermatitis	0.000173	0.000809	CcSEcCtD
Iloperidone—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000173	0.000807	CcSEcCtD
Iloperidone—Arthralgia—Methylprednisolone—atopic dermatitis	0.000173	0.000807	CcSEcCtD
Iloperidone—Myalgia—Methylprednisolone—atopic dermatitis	0.000173	0.000807	CcSEcCtD
Iloperidone—Eye disorder—Prednisone—atopic dermatitis	0.000173	0.000806	CcSEcCtD
Iloperidone—Tachycardia—Hydrocortisone—atopic dermatitis	0.000172	0.000803	CcSEcCtD
Iloperidone—Dry mouth—Triamcinolone—atopic dermatitis	0.000169	0.000791	CcSEcCtD
Iloperidone—Nausea—Tacrolimus—atopic dermatitis	0.000168	0.000784	CcSEcCtD
Iloperidone—Angiopathy—Prednisone—atopic dermatitis	0.000167	0.000782	CcSEcCtD
Iloperidone—Confusional state—Methylprednisolone—atopic dermatitis	0.000167	0.00078	CcSEcCtD
Iloperidone—Oedema—Triamcinolone—atopic dermatitis	0.000166	0.000775	CcSEcCtD
Iloperidone—Vertigo—Dexamethasone—atopic dermatitis	0.000166	0.000774	CcSEcCtD
Iloperidone—Vertigo—Betamethasone—atopic dermatitis	0.000166	0.000774	CcSEcCtD
Iloperidone—Arrhythmia—Prednisone—atopic dermatitis	0.000165	0.00077	CcSEcCtD
Iloperidone—Infection—Triamcinolone—atopic dermatitis	0.000165	0.00077	CcSEcCtD
Iloperidone—Hypotension—Hydrocortisone—atopic dermatitis	0.000165	0.000769	CcSEcCtD
Iloperidone—Infection—Methylprednisolone—atopic dermatitis	0.000165	0.000768	CcSEcCtD
Iloperidone—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000162	0.000758	CcSEcCtD
Iloperidone—Paraesthesia—Prednisolone—atopic dermatitis	0.000162	0.000757	CcSEcCtD
Iloperidone—Tachycardia—Triamcinolone—atopic dermatitis	0.000162	0.000757	CcSEcCtD
Iloperidone—Mental disorder—Prednisone—atopic dermatitis	0.000162	0.000755	CcSEcCtD
Iloperidone—Tachycardia—Methylprednisolone—atopic dermatitis	0.000162	0.000755	CcSEcCtD
Iloperidone—Malnutrition—Prednisone—atopic dermatitis	0.000161	0.00075	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000161	0.00075	CcSEcCtD
Iloperidone—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000158	0.000739	CcSEcCtD
Iloperidone—Myalgia—Dexamethasone—atopic dermatitis	0.000157	0.000734	CcSEcCtD
Iloperidone—Myalgia—Betamethasone—atopic dermatitis	0.000157	0.000734	CcSEcCtD
Iloperidone—Hypotension—Methylprednisolone—atopic dermatitis	0.000155	0.000723	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000152	0.000711	CcSEcCtD
Iloperidone—Fatigue—Hydrocortisone—atopic dermatitis	0.000152	0.00071	CcSEcCtD
Iloperidone—Vision blurred—Prednisone—atopic dermatitis	0.000151	0.000707	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000151	0.000706	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000151	0.000705	CcSEcCtD
Iloperidone—Oedema—Dexamethasone—atopic dermatitis	0.000151	0.000703	CcSEcCtD
Iloperidone—Oedema—Betamethasone—atopic dermatitis	0.000151	0.000703	CcSEcCtD
Iloperidone—Infection—Betamethasone—atopic dermatitis	0.00015	0.000699	CcSEcCtD
Iloperidone—Infection—Dexamethasone—atopic dermatitis	0.00015	0.000699	CcSEcCtD
Iloperidone—Paraesthesia—Triamcinolone—atopic dermatitis	0.000149	0.000696	CcSEcCtD
Iloperidone—Feeling abnormal—Prednisolone—atopic dermatitis	0.000149	0.000695	CcSEcCtD
Iloperidone—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000149	0.000694	CcSEcCtD
Iloperidone—Anaemia—Prednisone—atopic dermatitis	0.000149	0.000694	CcSEcCtD
Iloperidone—Dyspnoea—Triamcinolone—atopic dermatitis	0.000148	0.000691	CcSEcCtD
Iloperidone—Nervous system disorder—Betamethasone—atopic dermatitis	0.000148	0.00069	CcSEcCtD
Iloperidone—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000148	0.00069	CcSEcCtD
Iloperidone—Agitation—Prednisone—atopic dermatitis	0.000148	0.00069	CcSEcCtD
Iloperidone—Tachycardia—Dexamethasone—atopic dermatitis	0.000147	0.000686	CcSEcCtD
Iloperidone—Tachycardia—Betamethasone—atopic dermatitis	0.000147	0.000686	CcSEcCtD
Iloperidone—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000145	0.000678	CcSEcCtD
Iloperidone—Vertigo—Prednisone—atopic dermatitis	0.000144	0.000674	CcSEcCtD
Iloperidone—Fatigue—Triamcinolone—atopic dermatitis	0.000143	0.000668	CcSEcCtD
Iloperidone—Fatigue—Methylprednisolone—atopic dermatitis	0.000143	0.000667	CcSEcCtD
Iloperidone—Hypotension—Betamethasone—atopic dermatitis	0.000141	0.000657	CcSEcCtD
Iloperidone—Hypotension—Dexamethasone—atopic dermatitis	0.000141	0.000657	CcSEcCtD
Iloperidone—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000139	0.000651	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000137	0.000641	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000137	0.000641	CcSEcCtD
Iloperidone—Myalgia—Prednisone—atopic dermatitis	0.000137	0.000639	CcSEcCtD
Iloperidone—Arthralgia—Prednisone—atopic dermatitis	0.000137	0.000639	CcSEcCtD
Iloperidone—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000137	0.000639	CcSEcCtD
Iloperidone—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000136	0.000637	CcSEcCtD
Iloperidone—Paraesthesia—Betamethasone—atopic dermatitis	0.000135	0.000632	CcSEcCtD
Iloperidone—Paraesthesia—Dexamethasone—atopic dermatitis	0.000135	0.000632	CcSEcCtD
Iloperidone—Body temperature increased—Triamcinolone—atopic dermatitis	0.000131	0.000613	CcSEcCtD
Iloperidone—Oedema—Prednisone—atopic dermatitis	0.000131	0.000612	CcSEcCtD
Iloperidone—Infection—Prednisone—atopic dermatitis	0.00013	0.000608	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.00013	0.000607	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.00013	0.000607	CcSEcCtD
Iloperidone—Fatigue—Betamethasone—atopic dermatitis	0.00013	0.000606	CcSEcCtD
Iloperidone—Fatigue—Dexamethasone—atopic dermatitis	0.00013	0.000606	CcSEcCtD
Iloperidone—Nervous system disorder—Prednisone—atopic dermatitis	0.000129	0.000601	CcSEcCtD
Iloperidone—Tachycardia—Prednisone—atopic dermatitis	0.000128	0.000598	CcSEcCtD
Iloperidone—Asthenia—Hydrocortisone—atopic dermatitis	0.000126	0.000591	CcSEcCtD
Iloperidone—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000124	0.00058	CcSEcCtD
Iloperidone—Feeling abnormal—Betamethasone—atopic dermatitis	0.000124	0.00058	CcSEcCtD
Iloperidone—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000121	0.000563	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000119	0.000558	CcSEcCtD
Iloperidone—Dizziness—Prednisolone—atopic dermatitis	0.000119	0.000557	CcSEcCtD
Iloperidone—Asthenia—Triamcinolone—atopic dermatitis	0.000119	0.000556	CcSEcCtD
Iloperidone—Body temperature increased—Betamethasone—atopic dermatitis	0.000119	0.000556	CcSEcCtD
Iloperidone—Body temperature increased—Dexamethasone—atopic dermatitis	0.000119	0.000556	CcSEcCtD
Iloperidone—Asthenia—Methylprednisolone—atopic dermatitis	0.000119	0.000555	CcSEcCtD
Iloperidone—Paraesthesia—Prednisone—atopic dermatitis	0.000118	0.00055	CcSEcCtD
Iloperidone—Dizziness—Hydrocortisone—atopic dermatitis	0.000117	0.000544	CcSEcCtD
Iloperidone—Rash—Prednisolone—atopic dermatitis	0.000114	0.000531	CcSEcCtD
Iloperidone—Dermatitis—Prednisolone—atopic dermatitis	0.000114	0.000531	CcSEcCtD
Iloperidone—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000113	0.000529	CcSEcCtD
Iloperidone—Fatigue—Prednisone—atopic dermatitis	0.000113	0.000528	CcSEcCtD
Iloperidone—Rash—Hydrocortisone—atopic dermatitis	0.000111	0.000519	CcSEcCtD
Iloperidone—Dermatitis—Hydrocortisone—atopic dermatitis	0.000111	0.000519	CcSEcCtD
Iloperidone—Dizziness—Triamcinolone—atopic dermatitis	0.00011	0.000513	CcSEcCtD
Iloperidone—Dizziness—Methylprednisolone—atopic dermatitis	0.00011	0.000511	CcSEcCtD
Iloperidone—Feeling abnormal—Prednisone—atopic dermatitis	0.000108	0.000505	CcSEcCtD
Iloperidone—Asthenia—Dexamethasone—atopic dermatitis	0.000108	0.000505	CcSEcCtD
Iloperidone—Asthenia—Betamethasone—atopic dermatitis	0.000108	0.000505	CcSEcCtD
Iloperidone—Nausea—Prednisolone—atopic dermatitis	0.000107	0.000501	CcSEcCtD
Iloperidone—Nausea—Hydrocortisone—atopic dermatitis	0.000105	0.000489	CcSEcCtD
Iloperidone—Rash—Triamcinolone—atopic dermatitis	0.000105	0.000489	CcSEcCtD
Iloperidone—Dermatitis—Triamcinolone—atopic dermatitis	0.000105	0.000488	CcSEcCtD
Iloperidone—Rash—Methylprednisolone—atopic dermatitis	0.000104	0.000488	CcSEcCtD
Iloperidone—Dermatitis—Methylprednisolone—atopic dermatitis	0.000104	0.000487	CcSEcCtD
Iloperidone—Body temperature increased—Prednisone—atopic dermatitis	0.000104	0.000484	CcSEcCtD
Iloperidone—Diarrhoea—Dexamethasone—atopic dermatitis	0.000103	0.000481	CcSEcCtD
Iloperidone—Diarrhoea—Betamethasone—atopic dermatitis	0.000103	0.000481	CcSEcCtD
Iloperidone—Dizziness—Betamethasone—atopic dermatitis	9.96e-05	0.000465	CcSEcCtD
Iloperidone—Dizziness—Dexamethasone—atopic dermatitis	9.96e-05	0.000465	CcSEcCtD
Iloperidone—Nausea—Triamcinolone—atopic dermatitis	9.86e-05	0.00046	CcSEcCtD
Iloperidone—Nausea—Methylprednisolone—atopic dermatitis	9.84e-05	0.000459	CcSEcCtD
Iloperidone—Rash—Betamethasone—atopic dermatitis	9.5e-05	0.000443	CcSEcCtD
Iloperidone—Rash—Dexamethasone—atopic dermatitis	9.5e-05	0.000443	CcSEcCtD
Iloperidone—Dermatitis—Betamethasone—atopic dermatitis	9.49e-05	0.000443	CcSEcCtD
Iloperidone—Dermatitis—Dexamethasone—atopic dermatitis	9.49e-05	0.000443	CcSEcCtD
Iloperidone—Asthenia—Prednisone—atopic dermatitis	9.41e-05	0.000439	CcSEcCtD
Iloperidone—Diarrhoea—Prednisone—atopic dermatitis	8.97e-05	0.000419	CcSEcCtD
Iloperidone—Nausea—Dexamethasone—atopic dermatitis	8.95e-05	0.000418	CcSEcCtD
Iloperidone—Nausea—Betamethasone—atopic dermatitis	8.95e-05	0.000418	CcSEcCtD
Iloperidone—Dizziness—Prednisone—atopic dermatitis	8.67e-05	0.000405	CcSEcCtD
Iloperidone—Rash—Prednisone—atopic dermatitis	8.27e-05	0.000386	CcSEcCtD
Iloperidone—Dermatitis—Prednisone—atopic dermatitis	8.26e-05	0.000386	CcSEcCtD
Iloperidone—Nausea—Prednisone—atopic dermatitis	7.79e-05	0.000364	CcSEcCtD
Iloperidone—HRH1—GPCR downstream signaling—CCR5—atopic dermatitis	1.98e-05	0.000272	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCR3—atopic dermatitis	1.98e-05	0.000271	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	1.97e-05	0.00027	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	1.96e-05	0.000269	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCR3—atopic dermatitis	1.96e-05	0.000269	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	1.95e-05	0.000267	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCR3—atopic dermatitis	1.95e-05	0.000267	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TAC1—atopic dermatitis	1.94e-05	0.000267	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NPS—atopic dermatitis	1.94e-05	0.000267	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCR3—atopic dermatitis	1.94e-05	0.000266	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	1.93e-05	0.000265	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	1.9e-05	0.000262	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCR3—atopic dermatitis	1.9e-05	0.000261	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.89e-05	0.00026	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—CXCL8—atopic dermatitis	1.88e-05	0.000258	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—CXCL8—atopic dermatitis	1.88e-05	0.000258	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.87e-05	0.000256	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.86e-05	0.000256	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL5—atopic dermatitis	1.86e-05	0.000255	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CCL5—atopic dermatitis	1.85e-05	0.000254	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CXCL10—atopic dermatitis	1.85e-05	0.000254	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CCL5—atopic dermatitis	1.85e-05	0.000254	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	1.84e-05	0.000252	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	1.83e-05	0.000252	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CXCL10—atopic dermatitis	1.83e-05	0.000251	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.82e-05	0.00025	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.81e-05	0.000249	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.81e-05	0.000248	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	1.81e-05	0.000248	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	1.8e-05	0.000248	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	1.8e-05	0.000247	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—CXCL8—atopic dermatitis	1.8e-05	0.000247	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—IL2—atopic dermatitis	1.79e-05	0.000246	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—IL2—atopic dermatitis	1.79e-05	0.000246	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	1.78e-05	0.000245	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	1.77e-05	0.000243	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CCL5—atopic dermatitis	1.77e-05	0.000243	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	1.77e-05	0.000243	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NPS—atopic dermatitis	1.76e-05	0.000242	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TAC1—atopic dermatitis	1.76e-05	0.000242	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	1.73e-05	0.000238	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NPS—atopic dermatitis	1.73e-05	0.000238	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NPS—atopic dermatitis	1.73e-05	0.000238	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TAC1—atopic dermatitis	1.73e-05	0.000238	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	1.73e-05	0.000237	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—IL2—atopic dermatitis	1.72e-05	0.000236	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—NGF—atopic dermatitis	1.71e-05	0.000235	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—NGF—atopic dermatitis	1.71e-05	0.000235	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—CXCL8—atopic dermatitis	1.71e-05	0.000234	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—CXCL8—atopic dermatitis	1.7e-05	0.000234	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—NGF—atopic dermatitis	1.7e-05	0.000233	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	1.7e-05	0.000233	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	1.7e-05	0.000233	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	1.7e-05	0.000233	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	1.7e-05	0.000233	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.69e-05	0.000232	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CCR5—atopic dermatitis	1.67e-05	0.000229	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CCR5—atopic dermatitis	1.66e-05	0.000229	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	1.66e-05	0.000229	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	1.65e-05	0.000227	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—IL2—atopic dermatitis	1.65e-05	0.000227	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	1.64e-05	0.000225	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—NGF—atopic dermatitis	1.64e-05	0.000225	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL5—atopic dermatitis	1.64e-05	0.000225	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	1.63e-05	0.000224	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—IL2—atopic dermatitis	1.63e-05	0.000224	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—IL2—atopic dermatitis	1.63e-05	0.000224	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	1.62e-05	0.000222	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.62e-05	0.000222	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL5—atopic dermatitis	1.61e-05	0.000221	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL5—atopic dermatitis	1.61e-05	0.000221	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.6e-05	0.000219	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CCR5—atopic dermatitis	1.59e-05	0.000219	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CCL5—atopic dermatitis	1.59e-05	0.000219	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	1.59e-05	0.000218	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	1.58e-05	0.000217	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	1.58e-05	0.000217	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	1.58e-05	0.000217	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	1.58e-05	0.000217	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CCL5—atopic dermatitis	1.57e-05	0.000216	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—IL2—atopic dermatitis	1.56e-05	0.000214	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	1.55e-05	0.000212	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	1.55e-05	0.000212	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	1.54e-05	0.000211	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	1.52e-05	0.000209	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—NGF—atopic dermatitis	1.47e-05	0.000202	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	1.47e-05	0.000202	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	1.47e-05	0.000201	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.46e-05	0.0002	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—NGF—atopic dermatitis	1.46e-05	0.0002	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	1.45e-05	0.000199	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CCR5—atopic dermatitis	1.43e-05	0.000197	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CCR5—atopic dermatitis	1.42e-05	0.000194	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	1.41e-05	0.000194	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	1.41e-05	0.000194	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PPARA—atopic dermatitis	1.41e-05	0.000194	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—IL2—atopic dermatitis	1.4e-05	0.000193	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	1.4e-05	0.000193	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.4e-05	0.000192	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	1.4e-05	0.000192	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.39e-05	0.000191	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—IL2—atopic dermatitis	1.38e-05	0.00019	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	1.38e-05	0.00019	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.38e-05	0.000189	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	1.37e-05	0.000189	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	1.37e-05	0.000188	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	1.37e-05	0.000188	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PPARA—atopic dermatitis	1.37e-05	0.000188	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	1.36e-05	0.000187	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	1.35e-05	0.000185	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	1.35e-05	0.000185	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	1.35e-05	0.000185	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	1.33e-05	0.000182	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	1.32e-05	0.000182	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	1.32e-05	0.000181	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	1.29e-05	0.000177	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NGF—atopic dermatitis	1.27e-05	0.000174	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.26e-05	0.000173	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NGF—atopic dermatitis	1.26e-05	0.000173	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	1.26e-05	0.000172	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	1.25e-05	0.000172	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	1.23e-05	0.000169	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	1.23e-05	0.000169	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	1.23e-05	0.000168	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	1.22e-05	0.000168	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.22e-05	0.000168	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	1.22e-05	0.000167	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	1.21e-05	0.000166	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCL5—atopic dermatitis	1.2e-05	0.000165	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.2e-05	0.000165	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	1.2e-05	0.000165	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	1.2e-05	0.000165	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.2e-05	0.000165	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	1.19e-05	0.000164	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	1.18e-05	0.000162	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCL5—atopic dermatitis	1.18e-05	0.000162	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.18e-05	0.000161	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	1.17e-05	0.00016	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	1.17e-05	0.00016	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	1.16e-05	0.000159	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	1.15e-05	0.000158	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	1.15e-05	0.000157	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	1.12e-05	0.000154	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NGF—atopic dermatitis	1.11e-05	0.000153	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PPARA—atopic dermatitis	1.11e-05	0.000153	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	1.11e-05	0.000152	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NGF—atopic dermatitis	1.1e-05	0.00015	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NGF—atopic dermatitis	1.09e-05	0.00015	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.09e-05	0.00015	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	1.09e-05	0.00015	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	1.09e-05	0.000149	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCR5—atopic dermatitis	1.08e-05	0.000149	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	1.08e-05	0.000148	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	1.07e-05	0.000147	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.07e-05	0.000147	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	1.07e-05	0.000146	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCR5—atopic dermatitis	1.06e-05	0.000146	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL2—atopic dermatitis	1.06e-05	0.000145	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	1.05e-05	0.000144	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	1.04e-05	0.000143	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	1.04e-05	0.000143	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	1.04e-05	0.000143	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	1.04e-05	0.000143	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL2—atopic dermatitis	1.04e-05	0.000143	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PPARA—atopic dermatitis	1.02e-05	0.00014	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	1.02e-05	0.00014	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PPARA—atopic dermatitis	1.02e-05	0.00014	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	1.01e-05	0.000139	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	1.01e-05	0.000138	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	1.01e-05	0.000138	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	1e-05	0.000137	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	9.97e-06	0.000137	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	9.92e-06	0.000136	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	9.7e-06	0.000133	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	9.63e-06	0.000132	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL2—atopic dermatitis	9.63e-06	0.000132	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL2—atopic dermatitis	9.62e-06	0.000132	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—IL6—atopic dermatitis	9.58e-06	0.000132	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—IL6—atopic dermatitis	9.57e-06	0.000131	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL2—atopic dermatitis	9.56e-06	0.000131	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	9.51e-06	0.000131	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	9.48e-06	0.00013	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL2—atopic dermatitis	9.21e-06	0.000126	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	9.18e-06	0.000126	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—IL6—atopic dermatitis	9.16e-06	0.000126	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	9.03e-06	0.000124	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	9.02e-06	0.000124	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	8.86e-06	0.000122	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	8.85e-06	0.000122	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	8.85e-06	0.000121	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	8.8e-06	0.000121	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	8.67e-06	0.000119	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	8.56e-06	0.000118	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	8.47e-06	0.000116	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL2—atopic dermatitis	8.29e-06	0.000114	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—IL6—atopic dermatitis	8.25e-06	0.000113	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	8.22e-06	0.000113	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL2—atopic dermatitis	8.18e-06	0.000112	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—IL6—atopic dermatitis	8.14e-06	0.000112	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	7.63e-06	0.000105	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	7.53e-06	0.000103	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	7.46e-06	0.000102	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	7.42e-06	0.000102	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PPARA—atopic dermatitis	7.24e-06	9.95e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	7.22e-06	9.91e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL2—atopic dermatitis	7.13e-06	9.79e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	7.09e-06	9.74e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL2—atopic dermatitis	7.09e-06	9.74e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	7.06e-06	9.69e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	6.9e-06	9.47e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	6.86e-06	9.42e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	6.56e-06	9.01e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	6.55e-06	8.99e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	6.53e-06	8.96e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	6.44e-06	8.85e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	6.43e-06	8.83e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	6.35e-06	8.72e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	6.31e-06	8.66e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL2—atopic dermatitis	6.26e-06	8.59e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6—atopic dermatitis	6.23e-06	8.55e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL2—atopic dermatitis	6.16e-06	8.45e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL2—atopic dermatitis	6.14e-06	8.44e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARA—atopic dermatitis	6.14e-06	8.43e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	6.13e-06	8.41e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6—atopic dermatitis	6.11e-06	8.39e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	6.03e-06	8.28e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	6e-06	8.24e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	5.86e-06	8.05e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	5.76e-06	7.91e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	5.67e-06	7.78e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6—atopic dermatitis	5.66e-06	7.77e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	5.66e-06	7.77e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6—atopic dermatitis	5.65e-06	7.76e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6—atopic dermatitis	5.62e-06	7.71e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	5.6e-06	7.69e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	5.57e-06	7.65e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	5.55e-06	7.62e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6—atopic dermatitis	5.41e-06	7.43e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	5.16e-06	7.08e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6—atopic dermatitis	4.87e-06	6.69e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6—atopic dermatitis	4.81e-06	6.6e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.74e-06	6.5e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6—atopic dermatitis	4.19e-06	5.75e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6—atopic dermatitis	4.17e-06	5.72e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	4.05e-06	5.57e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6—atopic dermatitis	3.68e-06	5.05e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6—atopic dermatitis	3.62e-06	4.97e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6—atopic dermatitis	3.61e-06	4.96e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	3.54e-06	4.87e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	3.29e-06	4.52e-05	CbGpPWpGaD
